Public health, next cut?

30 12 2010

The European Union has recommended to States members who study health care co-payment formulas to reduce its impact on the public accounts. At the moment, is not a requirement, as it is the case with pensions; a recommendation only, but it is not difficult to imagine that the next step in the setting of the welfare State will go through the health. Soon we will see the rating agencies demanding quickly in your slimming. Elena Salgado as Leire Pajin said that Spanish expenditure is reasonable –the 5,5% of GDP, below the Community average– and they have refused the Government think about something, Although they have not ruled out in the future. Let us hope that the economy grows enough to reduce the deficit to the 6% in the 2011 and that markets do not impose more cuts.

In Spain we have been turning to this subject for decades, since formed the Commission April Martorell. Then, with health competencies transferred, the debate has been extended to the autonomies. In Catalonia, Vilardell Commission made a report on the 2005 and in July of the 2010 published the second. Although not all its members disagree, the headline/summary of both texts focuses on the copay. At the same time, specialists in business schools and corporate studies services do not stop manufacturing roles around the new financing needs and the containment of their spending. The basic lines of these analyses are avoiding saturation in the public system and reduce pharmaceutical purchases, involving more than the 20% spending, a proportion that it exceeds the EU average.

It is very likely that at the end you have to resort to the copay –repayment in happy definition of those who want to emphasize that health is already paid for by contributions of workers–, but it is a mistake to focus the debate on that issue. Salgado was Health Minister and as such fell by Decree the prices of medicines. It is true that these measures have reduced the 10% its cost, but the number of prescriptions has increased a 21% in the past six years.

At the moment, the Government develops a campaign to promote the consumption of generic among the population, that also appeals to rationally use health services. There is some resistance to these drugs in the insured, have the temptation of thinking that, being cheaper, they are less effective; but they are employees of the system, the optional, those who have to convince. Buy Social Security and their doctors are those prescribed. It is hoped that public health has other instruments, In addition to the campaign and the decrees. It would be nice, for example, give training to their doctors about the new generation medicines so they no longer be laboratories who put abreast of innovations.

The idea of the salvation of the public health system through the co-payment is permeating as fine rain. Polls say even that the greater part of the population it would well. Artur Mas said in his inaugural speech that is not “supporter” the copay, in the campaign when it was; the President of Navarre, Miguel Sanz , It has raised a rate for hospitalization. In the middle of two statements met the EU document and the response of the central Government. Your second statement, accompanied by announcements about privatization and benefits review, It is very similar to Salgado and Pajin. But Social Security has many inefficiencies, more than health management. Why do pay one euro per office visit to relieve congestion on it?, If the 30% of them are purely administrative and other 20% These are questions that could solve the nursing? Is not more logical avoid these improper medical functions?? The euro per visit may be deterrent, but for whom?? Probably, for which takes the bus with the pink card and for which that amount a constraint.

Some of the experts of the Commission Vilardell put the accent on the need that the health check your purchasing policy, including technology; to make a control of efficiency to improve before enter wage incentives to doctors and nurses and if patients must pay when they attend a service or consume a specific. They also include the possibility of obtaining resources of peripheral services, as the comfort in hospital admissions, but especially they insist that the income of patients to establish who is present, What and how much is paid in addition. They proposed to begin in case of recourse to the copay to modify which already operates in the purchase of medicines, It does not distinguish between a high income retiree and a worker with low pay and charges family. Or is, no escape from the profound changes, even more expensive than the formula easy to increase the co-payment and, in case that you need to increase, do it with criteria of social justice. [en línea] Cáceres (Spain): elelperiodicoextremadura.com9 December of 2010 [REF. of 30 in December of 2010] Available on Internet:

The ranking of the thousand companies that invest more in r & d is dominated by the healthcare industry

27 12 2010

Investment in research and development (R & D) is necessary to innovate, but does not guarantee the success. Apple and Google led in 2009 the classification of the thousand of the world's most innovative companies, Despite or the positions 81 and 44 in the ranking by r & d expenditure.

According to the annual report on innovation in the company, developed by strategic consultancy Booz & Company, These two companies, followed by 3 M (see attached graph), they are perceived as the most innovative in the world, in a classification based on surveys to executives of 450 companies in ten sectors, dominated by technology companies.

During the past year, investment in r & d of the thousand of the world's most innovative companies was reduced a 3,5%, hasta 503.000 millions of dollars (382.600 million euros), and it is the first fall in the last decade. However, in 2009, the joint turnover of these large companies fell a 11%, nearly three times more than spending on r & d, hasta 13,uplions of dollars, so the weight of investment in innovation against turnover grew, passing of the 3,46% to the 3,75% in the last year. In addition, the cut in r & d is less than the administrative costs (5,4%) and the investment in capital, that reduces a 17,5%.

The fall of total investment in r & d was driven by the automotive industry, reducing these costs a 14,3%, above the fall of billing, While the electronic and computer companies spent a 6,7% less than in the previous year in r & d, While those that remain more spend, con 136.921 millions of dollars in 2009, followed by the health sector (117.790 million) automotive and, con 73with1 millions of dollars of r & d expenditure.

By companies, pharmaceutical and health industry dominates the ranking investment, to occupy six of the top ten, with Microsoft, Nokia and Toyota as representatives of other sectors. By regions, Japanese companies reduced a 10,8% your investment in r & d, While the United States has invested a 2,8% less and Europe remained stable as regards 2008.

For Jose Arias, Vice President of Booz & Company, "the report shows that the amount of money invested in r & d does not guarantee success", the money does not buy results, "since the important thing is to align with the company's innovation strategy". In fact, Arias stands out as "companies that are regarded as more innovative", as Google and Apple, "match in efficiently managing the processes of creation and marketing of new products".

For the first time, Telefónica appears among the most innovative in the world for investment companies, in the post 106. They also enter Almirall and Abengoa, While repeated actuates and Zeltia. Para Arias, the most significant input is the company chaired by César Alierta. According to the Vice President of Booz & Company, "Telefónica has seen the need to efficiently invest in innovation", before the revolution that Internet companies, very innovative, "they are putting in the business". Para AriFor Ariaspositive that the operator "has restructured its r & d area and have created new lines of innovative businesses" in the Group.


- The ranking of the thousand companies that invest more in R & d is dominated by the health care industry, with Roche as a leader, and presence of technological, like Nokia and Microsoft.

- Despite not be placed between the companies that more invirtien, Apple and Google are the two companies most cited by large groups such as the most innovative executives.

- Among the Spanish companies, Telefónica bursts in with force in the ranking of the most innovative companies, in the post 106, with presence of Zeltia and Almirall.

BusinessWeek [en línea] Madrid (Spain):, 27 de diciembre de 2010 [REF. 23 in December of 2010] Available on Internet:

Engineering Biomechanics for spinal cord injuries

23 12 2010

A team of engineering Biomechanics of the UPC works in the custom design of devices for spinal cord injuries.

The project develops a multidisciplinary team of engineers, doctors and Orthopedic Center for research in biomedical engineering from the UPC (CREB) in collaboration with the University of La Coruña and the University of Extremadura.

There is a laboratory of biomechanics for the dynamic analysis of human walking. This space is equipped with a motion capture system with infrared cameras to measure the movement of the human body while walking,and it also allows to measure the force of contact between the foot and the ground through force plates.

The measures are used to study human walking, both healthy people and spinal cord injured patients that carry personal devices that help walk. For these people, a simulation program is being developed by computer which will be used to design customized assistive devices.

Currently working on the design of an active knee and ankle orthosis to assist the progress of injured spinal cord incomplete. The main contributions of this prototype are the automatic control of the movement from smart sensors, and low energy consumption that favours the autonomy of the device.

The purpose of the project is the custom design of assistive devices for each specific case of spinal cord injury, improvement of the autonomy of the patient and its process of adaptation to the device, that translates into a better quality of life, saving time and money in the obtaining of the final product.

In the following video you can learn more about the work of this research group. The video aired on Saturday 18 December by Televisió de Catalunya is in catalan; but has subtitles in Spanish. To activate it you must press on the lower button CC. Subtitles can be seen only in the latest versions of browsers or directly from Youtube. We apologize for the inconvenience. [en línea] Barcelona (Spain): tvTV3.catREF. of 23 in December of 2010] Available on Internet:


A stimulating greeting, fast, ecological and economic part of DOCTOPOLIS

21 12 2010

Thank you very much for your support and dedication!
Happy Christmas from DOCTOPOLIS team!

A spinal cord injured young man creates a foundation for the cure of spinal cord injuries

20 12 2010

It all started with the accident of Carles. Your need and personal determination led him to restore as soon as possible and discover a new situation in which had to dump all your dedication.

Travel, attend conferences, meet scientific specialists in the regeneration of spinal cord injuries and exchange ideas with others involved with a similar vocation, they made him get down to work. Was noted that there was much work to be done and that it should begin as quickly as possible to change things. Thus was born Fenexy.

Fenexy It is a non-profit organization formed by a diverse team of people, Since people with spinal cord injuries to scientists and professionals from different specialties. The entire team works together with illusion and force to achieve a major milestone: cure spinal cord injuries.

Although it is a single goal, must be tackled the challenge from different points. Why Fenexy is multidisciplinary and divides it into multiple tasks: promotion and financing of basic and clinical research, proven and close information for persons with spinal cord injury and family, social impact and fundraising events, involvement of society with the progress of the cure of spinal cord injuries, establishment of bridges of communication between research entities etc.

Currently the Fenexy Foundation does not receive any Government funding. Its funding comes mainly from individual donations.

You can learn to Carles and its history in this video broadcast by Televisió de Catalunya (TV3) last Thursday 15 December.

The video cannot be viewed with the INTERNET EXPLORER browser by an insurmountable incompatibility problem, but with FIREFOX I GOOGLE CHROME browsers. We apologize for the inconvenience. If you surf with INTERNET EXPLORER, You can view the video at this link:

[VodPod id = Video. 5146904&w = 425&h = 350&fv=hassinopsi=true&autostart=false&comentaris=false&haspodcast=true&instancename=playerEVP_0_3269030&videoid=3269030&minimal=false&subtitols=true&hasrss=true&refreshlock=true&mesi=true&backgroundColor=#ffffff&basepath=] [en línea] Barcelona (Spain): [REF. of 20 in December of 2010] Available on Internet:

Business models for electronic health

16 12 2010

The present report, funded by the health services of the Directorate-General for ICT, the study of new models of business that promote sustainable systems and value creation for the eHealth in Europe shows. By value mean an electronic health system capabilities which provide socio-economic and health improvements both for patients and for health professionals. For sustainability, we understand a system of electronic health that has passed the pilot stage and is fully operational to generate and analyze data according to parameters preset by a series of indicators. In addition, This Studio offers a series of recommendations to the European Commission and other potential partners, the main objectives are:

  • The overall improvement of the quality and efficiency in health services through electronic health, to take into account the present and future socio-economic conditions as well as the financial challenges faced by the various national health authorities in Europe.
  • The consolidation of the services of eHealth as a mature market where the European Union can play a role of global leadership through the provision of technology and innovative solutions.

In this report, the analysis of electronic health business models is a subsidiary of information technologies, and under the premises of value creation and sustainability of these models should reverse improvements in medical treatment, Security, quality , timeout, effectiveness and efficiency.

The methodological approach used for the preparation of the analysis includes a review of the status of the issue of electronic health accompanied by interviews with European experts in the sector. Also focuses on four current cases of models with creation of eHealth in Europe sustainability and value, In addition to a final workshop where electronic health experts contribute views and ideas on public policy at the national and international levels.

The design of business models of value creation and sustainable need to analyze all the essential value chain activities, as well as their relationships and dependencies arising from the introduction of electronic health services. The structuring and implementation of these business models requires involvement and management effective at every stage of the design, as well as guaranteeing the necessary funding through all phases of development. In essence, requests to service personnel are involved in the design of business models of electronic health and be given the opportunity to understand the changes that will affect your activity. All these activities are important in that they can predict possible interactions or changes in the development of procedures of eHealth in the day to day of actors who should run it.

Beyond the implementation of specific operational policies, It is necessary for the promotion of new models of electronic health to ensure packages of public to encourage the development of models of value creation and sustainable measures referred to. This requires the participation of the parties concerned, as national health authorities, health professionals associations, health organizations, industries and scientific communities. Specifically, the study identifies the European Commission as an ideal agent for vehicle the creation of the following business models for electronic health:

  • Launch projects in pilot phase where testen different business models;
  • Share best practices for the design of business models of creating value and sustainability;
  • Define benchmarks that allow organizations to monitor and compare the development and implementation of models of electronic health;
  • Support the development of the process of investment and financing systems of eHealth through incentives such as tax rebates, mechanisms of co-financing and / or reimbursement procedures;
  • Bring legal clarity in order to facilitate the identification and authentication of access of medical personnel to the health data, the secure exchange of medical data at the national level safeguarding the personal integrity of the patient as well as their right to be consulted about the transfer of data, and
  • Guide the work towards the solution of technical standards and facilitate the development of the market through interoperability, the unification of medical terminologies and activities. [en línea] Mataró, Barcelona (Spain): December of 2010 [REF. of 15 in December of 2010] Available on Internet:


Valeri, (L).. Business Models for eHealth. RAND Europe. 2010 [access 15 December 2010]. Available to: Business Models for eHealth (PDF)

African Innovation: New Hope for Local Health Issues

13 12 2010

“These papers offer important lessons that can help to guide Africa and its international partners to complement 20th century policies on access to essential medicines and technology with 21st century approaches that focus on building health innovation systems. Those who take this route will find these papers highly valuable and timely.” -Calestous Juma

Dr. Peter Singer and Dr. Ken Simiyu discuss the findings of their research in a passionate studio discussion, African Innovation: New Hope for Local Health Issues.

The Problem

It has not been well understood what capabilities African countries, with their high disease burden, have in science-based health innovation. International health policy debates have been guided by the idea that Africa will remain a marginal player in the world of health innovation and will continue to rely on imported solutions.

The research of McLaughlin-Rotman Centre for Global Health

In December 2010, the McLaughlin-Rotman Centre for Global Health published a landmark series of papers that provide a unique perspective on the experience of countries and companies in Sub-Saharan Africa addressing health problems through local innovation.

The key finding of this research is that although African countries have strong capabilities in internalizing foreign health innovations, and especially in developing their own home-grown ideas and translating these into products and services, there are barriers to getting discoveries to the marketplace. The barriers are access to venture capital, the culture of the scientific community in Africa, need for equipment and infrastructure to validate discoveries, issues around intellectual property and regulatory infrastructure.

The results of these papers provide clear policy prescriptions on how African countries can help strengthen their emerging innovation systems to improve health outcomes while contributing to overall economic diversification.

Case Studies

Malaria Treatment

The series presents the results of extensive on-the-ground interviews in Ghana, Kenya, Madagascar, Nigeria, Rwanda, South Africa, Tanzania, and Uganda in the form of four country case studies of health and biotechnology innovation, six studies of institutions within Africa involved in health product development, one study of health venture funds, and one study of stagnant health technologies.

Medical-Waste Incinerator

All of the examples that these case studies have produced, highlight pioneering attempts to build technological capacity, create economic opportunities and retain talent on a continent significantly affected by brain drain. The country case studies demonstrate the potential for innovation, while the institutions and companies and technology studies give real examples of technologies being developed. All countries exhibited a wide range of locally developed technologies: active pharmaceutical ingredients in Madagascar, medical devices in Tanzania and Uganda, diagnostics in Kenya and Ghana and traditional plant medicine technologies in Nigeria, among numerous others.

What are the Next Steps?

The authors of these papers challenge international agencies, donors and African governments to support and nurture local African innovative enterprises from a policy, funding and regulatory perspective because they can make a major contribution to better health in developing countries – and to their own health. Specifically, the authors propose the development of Life Science Innovation Centers that combine science, capital and entrepreneurship to provide scientists with the right environment to develop technologies that address local health issues. [en línea] Ontario (Canada): 25 November of 2010 [REF. in December of 2010] Available on Internet:

How can you help the telemedicine to the provision of integrated health care??

9 12 2010

Medical care at distance reduces costs and frees up the overload of work professionals. A report by the European Office of the World Health Organization analyzes various practices of telemedicine in Europe: monitoring of patients with heart problems, communication distance between professionals, single registration of health information systems, analysis of vital parameters from the home, etc. There is still an obstacle to overcome before the widespread use of these technologies has been achieved, However the experiences carried out until today continue to demonstrate its effectiveness.

In recent years, the advancement of ICT has helped decisively to the development of an integrated health care. Medical services to remote or telemedicine is where he has had more impact.
The improvement of the living conditions and the progressive decline in the birth rate have led to a progressive ageing of the population in Europe. In this way, have been increased also age-related chronic diseases, certain types of cancer and dementia. Other diseases reflect the impact of the change in lifestyle (higher levels of obesity and sedentary lifestyle), diabetes and cardiovascular diseases. It's patient needs continuous care, for which telemedicine and especially distance tracking systems can be of great help.

However, the introduction of these new technologies presents several problems: the selection of patients for certain types of benefits the use of which has not still been standardized, the privacy of medical information and its management, transparency in processes, the informed consent of the patient, etc. There is a legal framework adapted to the peculiarities of new services, or a consensual professional regulation. So far you can only speak of specific applications where new technologies with different objectives have been used. By comparing the various action codes adopted in these cases, best practices can be identified in order to facilitate a coherent legislative reform on the subject. Without guarantees of security, Neither users nor the professionals will be willing to open up to the use of new technologies.

Another obstacle to overcome is the reluctance to change of professionals and the limited capacity of innovation in organizations where work. If the parties concerned are actively involved in the reform, develops a sense of ownership on the results, that in turn facilitates the adoption of new structures. On the other hand, the necessary investment in equipment and training of professionals can curb the aspirations of modernization of the health centres, restricted by their budgets.

Despite all these obstacles, various applications of telemedicine in Europe have demonstrated their effectiveness in improving patient care and reduce costs:

Denmark. Integration between hospitals and primary care centers
When in Denmark a patient admitted to a hospital are automatically notified with a message to the competent local authorities in home medical care. When the patient is discharged from alta, automatically sends another message with all the care you need. Also reporting the family doctor, with an electronic document, to enable it to arrange medical treatment or rehabilitation plan most suitable for the patient.

Andalusia, Spain. A single data-logging system: Diraya
Diraya is a system of electronic patient record, accessible to all health care providers, at any time and from anywhere in Andalusia: hospitals, primary care centers, pharmacies. From 1999 they are more than centralized 1.000 databases. Have been reduced in a 15% visits of patients with chronic diseases to practitioners, and in a 10% absenteeism in consultations of specialists.

Lombardy, Italy. A telematics network to connect users and providers
This network offers specialized services of Varela patients in special conditions: with chronic heart disease, on waiting list for a heart transplant or other types of cardiac surgery and those who need a multidisciplinary follow-up on-site. The electrocardiograms of patients data is transferred to a call center where they are supervised by a team of nurses, that you can, at the same time, transmit information to a team of cardiologists from any part of the Lombardy. This practice has resulted in a reduction of the 35% the number of hospital admissions, a 12% visits less than external patients seeking hospital care and a reduction of 15 days in waiting for the start times or the modification of therapy in the 14% cases.

Germany. Telemedicine in chronic disease control
A background of the TAUNUS BKK health insurance company incorporates Telecare services from the 2007. Used especially for the follow-up of patients with diabetes or risk of heart failure. According to medical indication, certain vital parameters such as blood sugar level, body weight, the EKG and blood pressure, they are controlled by a home care unit. Captured data are automatically stored in a personal record. When the recorded values exceed the limits laid down, the system alerts a team of qualified personnel. In addition, patients receive counselling in nutrition, exercise and pharmacotherapy.

Sweden. The ACTION service for elderly people and their assistants
This service includes access to information and distance training programmes tailored to each case to facilitate self-management of patients. Attendees can request support local centres of health care when they need it. Studies show that attendees feel confident and competent in the performance of their duties, While patients and their families receive the support received by a more integrated network.

To achieve the implementation of new technologies successfully, We must encourage dialogue between professionals, different entities providers, patients and their families, and the responsible official bodies in the matter. The innovation process should include a proper staff training and a regularization of the new safety practices to users. Seeing the success of the examples cited, telemedicine is emerging as an ideal practice to free public health systems overload posed by population ageing and sedentary. [en línea] Mataró, Barcelona (Spain): ddiciembree of 2010 [REF. of 8 in December of 2010] Available on Internet:


Stroetmann, K. A. , [et. to the.]. How can telehealth help in the provision of integrated care?. World Health Organization. 2010 [access 8 December 2010]; Available on internet: How can telehealth help in the provision of integrated care? (PDF)

RODES Dr: Translational research 1 and 2

6 12 2010

Dr. Joan Rodés Teixidor

Chairman of the Institut d' Investigació Sanitària Clínic-IDIBAPS

The recent complete sequence of the human genome has clearly marked the future of biomedical research and innovation. Genomics, Proteomics, metabolomics, among other technologies newly developed bioengineering such as nanotechnology, molecular imaging and pharmacogenomics require intense collaboration with clinical research. Without their participation it would be impossible to obtain a correct phenotyping of tissue samples obtained from patients in hospitals. The discovery of new therapeutic targets only be obtained precisely whether this collaboration. On the other hand the translation of the knowledge generated by basic research to clinical research is not so easy or quick. Nor is there a logical and simple system that allows to communicate medical problems detected by clinical activity basic researchers. In short, It is evident that translational research must be understood as a form of research that includes the application of discoveries in basic biomedical science to the clinic and, at the same time, consider that it is the most suitable form from relevant scientific questions of the clinical activity (Translational research 1).

Translational research cannot be conducted in the basic departments of the University or in exclusive research institutes of molecular biology, Since the researchers of these centres do not have appropriate clinical knowledge, in the absence of hospitals where complete. Is for this reason that the centers combining both types of research by the collaboration between universities, centers of basic research and high level of care and with excellent clinical research hospitals, they are ideal for this type of research. With the combination of both types of research all parties win. First of all, translational research and medical care improves and, in the second place, It is a potent stimulus for basic researchers conduct a more realistic investigation that will benefit in the short to medium-term medical care.

In short, translational research 1 It consists of applying basic scientific knowledge to clinical research. The sequencing of the human genome has yielded a great information but for research biomedical true and high level it is necessary that there is a large system of translational research 1, in particular, as already mentioned above, focused on phenotypic studies. University hospitals that have managed to successfully integrate networks or health systems as a whole, with well-defined populations and groups of well-trained clinical researchers, probably, You can integrate a great platform for genomics research, with Exchange of two-way information between basic and clinical researchers and, with the development of large genetic databases, phenotypic, clinical and pharmacological. To do this, It will also require a remarkable development of the medical informatics and bioinformatics.

In the event that translational research 1 It has developed very positively there is no guarantee that the results obtained are effectively transferred to global medical practice and public health (Translational research 2). In effect, in a study in the US found that, While long overdue, there is consistent evidence, the beta-blockers are only being used in the 62,5% of the patients with coronary insufficiency, Statins in the 50% cases and aspirin in a 30% patients with coronary artery disease. The solution of this problem is not easy. To get that translational research 2 successful further training is required on the one hand
scientific healthcare physicians and, on the other hand, improve the quality of care through independent control instruments such as professional associations, the medical scientific societies or through the technology assessment agencies and medical research. (Agency for Health Care Research and Quality of U.S., National Institute of Health and Clinical Excellence in the United Kingdom, Swedish Council on Technology Assessment and Health Care in Sweden, Alberta Heritage Foundation for Medical Research in Canada). These agencies need to be transparent in its processes, regardless of how they work, able to assess methodological rigour and agile to not become a brake on the technological development.

The new tobacco law will not hurt the catering according to the SEE

2 12 2010

As a result of statements to the media made by representatives of the tobacco and the patron of hospitality in the last days, the Society Spanish of epidemiology (SEE) recalls that the reform of the law on sanitary measures against smoking extends to workers hospitality the protection enjoyed by January of 2006 the vast majority of workers in our country. Groups that stayed aside from this reform have followed in their great majority exposed to unacceptable levels of environmental tobacco smoke, irritating multicomponent mixture, toxic and carcinogenic, that is to say, capable of inducing cancerous mutations in humans.

Ambientes libres de Humo

In this context, the SEE welcomed the reform of the law, and expects policy changes to avoid much of the most of 1200 annual deaths attributable to passive smoking in Spain, If take into account only those due to lung cancer and cardiovascular disease. In fact, among the most of 800.000 hospitality workers currently exposed to environmental tobacco smoke regularly, it has been estimated that they could occur 1000 cancer cases follow exposed continuously during their working lives to the levels observed in recent studies. Contrary to what some organizations of the catering industry have expressed, the SEE insists that scientific evidence, derivative of multiple and rigorous studies carried out by independent researchers, It highlights the absence of economic damage in countries that have already implemented these rules. On the other hand, an increase in economic activity in this sector could be expected, Since allow reform to the 70% the population of this country (non-smoking rooms) enjoy these spaces of entertainment without having to expose an absolutely avoidable risk. The reform of the law will allow us to obtain short-term and long-term benefits on the health of the people. The evaluation of the Act of 2005 He showed that the initiative reduced in more than one 10% myocardial infarction, In addition to reducing respiratory symptoms among workers exposed after the implementation of the law.


At last, as noted in the evaluation of the Act of 2005, experience simple and easy to interpret measures recommended, as it is the ban, Since any other measure likely to be subject to arbitrary interpretations, and you can depend on the capacity of monitoring and inspection. In addition, There is evidence that clearly indicate that the technological ability to renew the air polluted by tobacco smoke is limited. Even when apparently the air is clean or clean we can detect the harmful components of tobacco smoke, that you are not visible nor noticeable from the olfactory point of view, What makes them particularly dangerous.


For all these reasons the SEE hoped that the reform of the law finally adopted in the terms in which it has been raised to advance so seamless in the protection of the health of the population and in particular of the most vulnerable groups, in this case the catering workers.


Society service Spanish [en línea] Madrid (Spain): THE NEW TOBACCO LAW WILL PROTECT THE HEALTH OF WORKERS WITHOUT PREJUDICE TO ECONOMIC TO THE INNKEEPERS. 20 November of 2010 [REF. of 1 in December of 2010]. Available on Internet: Note of the Spanish society of epidemiology in support of the reform of the tobacco act (PDF).